Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience-Reference-Cited by-同舟云学术

Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience

Published:2016-08-01 Issue:9 Volume:30 Page:1159-1164
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Puttarajappa Chethan¹,Bhattarai Manoj¹,Mour Girish¹,Shen Chengli²,Sood Puneet¹,Mehta Rajil¹,Shah Nirav¹,Tevar Amit D.³,Humar Abhinav³,Wu Christine¹,Hariharan Sundaram¹

Affiliation:

1. Renal-Electrolyte Division; Department of Medicine; University of Pittsburgh; Pittsburgh PA USA

2. Section on Biomarkers and Prediction Modeling; Department of Medicine; University of Pittsburgh; Pittsburgh PA USA

3. Department of Surgery; Thomas E. Starzl Transplantation Institute; University of Pittsburgh; Pittsburgh PA USA

Publisher

Wiley

Subject

Transplantation

Reference21 articles.

1. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation;Arthurs;Clin Infect Dis,2008

2. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients;Sagedal;Transplantation,2000

3. Human cytomegalovirus and kidney transplantation: a clinician's update;De Keyzer;Am J Kidney Dis,2011

4. OPTN/SRTR 2013 annual data report: kidney;Matas;Am J Transplant,2015

5. Rabbit antithymocyte globulin versus basiliximab in renal transplantation;Brennan;N Engl J Med,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients;Transplantation Direct;2023-07-12

2. Circulating NKG2C + NK cell expressing CD107a/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients;Transplant Immunology;2021-12

3. Development of CMV‐specific cytotoxic T cells (CMV‐Tc) in pediatric renal transplant recipients with CMV viremia;Pediatric Transplantation;2021-08-14

4. Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab;International Journal of Infectious Diseases;2021-06

5. Bimonthly viral monitoring for late‐onset cytomegalovirus infection in kidney transplant recipients;Clinical Transplantation;2021-03-05